Reversible neurostimulation implant to restore hearing for patients with sensorineural hearing loss beyond hearing aid benefit.
Auricle is developing a breakthrough neurostimulation implant for patients with sensorineural hearing loss who no longer benefit from hearing aids but are not prepared for a cochlear implant. The device uses a minimally invasive, reversible surgical approach that preserves remaining natural hearing—addressing the key concerns that prevent most patients from pursuing cochlear implants. It originated from Stanford Biodesign and is backed by Y Combinator, StartX, and Fogarty Innovation. Auricle Neurostimulation Implant is a product of Auricle.